TY - JOUR
T1 - Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral Therapy
AU - Asmuth, David M.
AU - Thompson, Corbin G.
AU - Chun, Tae Wook
AU - Ma, Zhong Min
AU - Mann, Surinder
AU - Sainz, Talia
AU - Serrano-Villar, Sergio
AU - Utay, Netanya S.
AU - Garcia, Juan Carlos
AU - Troia-Cancio, Paolo
AU - Pollard, Richard B.
AU - Miller, Christopher J.
AU - Landay, Alan
AU - Kashuba, Angela D.
N1 - Publisher Copyright:
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected].
PY - 2017/11/1
Y1 - 2017/11/1
N2 - Plasma, duodenal, and rectal tissue antiretroviral therapy (ART) drug concentrations, human immunodeficiency virus (HIV) RNA and HIV DNA copy numbers, and recovery of mucosal immunity were measured before and 9 months after initiation of 3 different ART regimens in 26 subjects. Plasma and tissue HIV RNA correlated at baseline and when 9-month declines were compared, suggesting that these compartments are tightly associated. Antiretroviral tissue:blood penetration ratios were above the 50% inhibitory concentration values in almost 100% of cases. There were no correlations between drug concentrations and HIV DNA/RNA. Importantly, no evidence was found for residual viral replication or deficient tissue drug penetration to account for delayed gastrointestinal-associated lymphoid tissue immune recovery.
AB - Plasma, duodenal, and rectal tissue antiretroviral therapy (ART) drug concentrations, human immunodeficiency virus (HIV) RNA and HIV DNA copy numbers, and recovery of mucosal immunity were measured before and 9 months after initiation of 3 different ART regimens in 26 subjects. Plasma and tissue HIV RNA correlated at baseline and when 9-month declines were compared, suggesting that these compartments are tightly associated. Antiretroviral tissue:blood penetration ratios were above the 50% inhibitory concentration values in almost 100% of cases. There were no correlations between drug concentrations and HIV DNA/RNA. Importantly, no evidence was found for residual viral replication or deficient tissue drug penetration to account for delayed gastrointestinal-associated lymphoid tissue immune recovery.
KW - ART tissue penetration
KW - HIV persistence
KW - antiretroviral concentration
KW - gastrointestinal-associated lymphoid tissue
KW - immune reconstitution
UR - http://www.scopus.com/inward/record.url?scp=85035050110&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85035050110&partnerID=8YFLogxK
U2 - 10.1093/infdis/jix418
DO - 10.1093/infdis/jix418
M3 - Article
C2 - 28968888
AN - SCOPUS:85035050110
SN - 0022-1899
VL - 216
SP - 813
EP - 818
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 7
ER -